Scientific and educational activities

ERIC meetings, 2024

  • ERIC International Preceptorship—Amsterdam, The Netherlands, April 5–6, 2024
  • ERIC International Preceptorship—Milan, Italy June 3-7, 2024
  • General Assembly of ERIC Members at the EHA2024 Congress—Madrid, June 13, 2024
  • ERIC International Meeting—Barcelona, September 26-28, 2024
  • ERIC International Preceptorship—Belgrade, Serbia, November 15–16, 2024
  • ELN Breakfast Meeting at the ASH Annual Meeting & Exposition—San Diego, December 8, 2024

ERIC projects, 2024

  • RESOLVE Trial: an international, multi-center, randomized, controlled pragmatic clinical trial
  • Central Nervous System CLL, a Rare Disease with Unclear Management
  • Dissecting the Novel Treatment Landscape for CLL in Europe and Identifying a New “High-Risk” Category in Patients with M-CLL: An ERIC Real World Evidence Study
  • Immunoglobulin Gene Sequence Analysis in CLL in the Era of Next-Generation Sequencing
  • Retrospective Study of Outcomes in TP53 Mutated and/or Deleted CLL Treated with Chemotherapy-Free Front Line Targeted Therapies
  • Clinical Outcomes of Patients with CLL Belonging to Different Stereotyped Subsets
  • CLL Treatment Compass
Share